Over-the-counter sale of 14 steroid creams has been banned by the Health Ministry

The Indian health ministry made amendments to certain rules of the Drugs and Cosmetics Rules, 1945 and put 14 steroid-based creams and ointments under the Schedule H category.

This step has been taken to stop the indiscriminate sale of topical preparations containing steroids and antibiotics without the prescription.

Actually, this move is the result from the complaint made by the dermatologists where they clearly mentioned that many of their patients used steroid- based creams and ointments without medical supervision as many of the pharma companies were selling them freely over the counter.

The notice was released by the Health Ministry on this change in the March 2018. Drugs Technical Advisory Board (DTAB) also had submitted their consideration to Central Drugs Standards Control Organisation (CDSCO) regarding the ban on steroid based creams and ointments. Finally, Health Ministry made a decision with the consultation DTAB and CDSCO.

These rules are not applicable for ordinary face-cleansing and moisturizers. Some of the common creams that get banned are alclometasone, beclomethasone, and desonide etc.

Related Posts

Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

Patients for Patient Safety Foundation (PFPSF) Partners with CAHO to RollOut an Excellence Program New Delhi: Thanks to some well-meaning organizations, patients are going to be lord of all they…

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction